$0.29
+0.01 (+2.29%)
Open$0.29
Previous Close$0.28
Day High$0.30
Day Low$0.27
52W High$9.70
52W Low$2.11
Volume—
Avg Volume11.2K
Market Cap2.42M
P/E Ratio—
EPS$-2.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,121.1% upside
Current
$0.29
$0.29
Target
$3.54
$3.54
$2.21
$3.54 avg
$4.26
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 191.65M | 164.31M | 4.60M |
| Net Income | -37,546,478 | -28,971,047 | 612.3K |
| Profit Margin | -19.6% | -18.6% | 13.3% |
| EBITDA | -33,438,348 | -27,234,594 | 960.1K |
| Free Cash Flow | — | — | 405.9K |
| Rev Growth | +16.6% | +16.6% | +11.5% |
| Debt/Equity | 3.44 | 3.44 | 0.89 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |